Tox21 Assay Nomination Form
Tox21 is the collaboration between the National Center for Computational Toxicology of the U.S. EPA,
the National Toxicology Program of the National Institute of Environmental Health Sciences, the NIH
Chemical Genomics Center of the NIH National Center for Advancing Translational
Sciences (NCATS), and the U.S. Food and Drug Administration. The participating agencies work together to
develop, validate, and translate innovative high throughput screening (HTS) methods to characterize
the impact of chemicals on key steps in toxicity pathways. This nomination form provides the public
an opportunity for input into the selection of HTS assays in Tox21.
View more information about NICEATM support of the Tox21 initiative
Proposed assays should be compatible with the
guidelines for HTS assays as described on the NCATS website
 .
Please use the form below to nominate high throughput screening toxicity assays to NICEATM
to evaluate for potential use in the Tox21 testing program. Please complete all fields, as this
will enable the best evaluation of the nominated method.
Members of the collaboration will evaluate submissions on an ongoing basis. Please provide contact
information as submitters may be contacted for additional information. Please note that the
submitter will not necessarily receive feedback on submissions unless selected for screening.
If you have additional questions about nominating an assay to Tox21, please contact
Dr. Warren Casey at NICEATM. If you would like to register for a workshop or contact NICEATM for any other reason, please use
the appropriate link above.
If you would like to comment on the website or report a missing page or broken link on the ICCVAM website,
please email the Webmaster.
|
